Table 3.
Tube | Content |
---|---|
1 | Cells without markers |
2 | Isotypic control |
3 | CD90 FITC/CD105 PE/7-AAD PERCP/CD34 PE-CY7/CD73 APC/CD45 APC-CY7 |
4 | HLA-DR FITC/CD13 PE/7-AAD PERCP/CD34 PE-CY7/CD45 APC-CY7 |
FMO | CD105 PE/7-AAD PERCP/CD34 PE-CY7/CD73APC/CD45 APC-CY7 |
FMO | CD90 FITC/7-AAD PERCP/CD34 PE-CY7/CD73 APC/CD45 APC-CY7 |
Fluorescence Minus One (FMO).